Radius Health Lands $27,650,000 New Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6030860e-ad1b-4da4-b26f-44cad1ea04b1&Preview=1 -
Date
11/25/2011 -
Company Name
Radius Health -
Mailing Address
201 Broadway 6th floor Cambridge, MA 02139 -
Company Description
Radius is a leading company in the discovery and development of a new generation of drug therapies for osteoporosis and women’s health. -
Website
http://www.radiuspharm.com -
Transaction Type
Debt, Venture Equity -
Transaction Amount
$27,650,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Radius will use the proceeds from the second tranche primarily to continue advancing the ongoing Phase 3 clinical study of BA058 Injection, the company’s novel anabolic (bone-building) drug for the treatment of osteoporosis. -
M&A Terms
-
Venture Investor
Healthcare Financial Services -
Venture Investor
Oxford Finance Corporation -
Venture Investor
GE Healthare Financial Services -
Venture Investor
Undisclosed
